Delivery Order SPE2DR25D1205-SPE2DR26F0WP4
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $14,061.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), carries an ultimate completion date of September 3, 2025, and involves no set-aside designation....
- The Defense Logistics Agency (DLA) awarded a $9,374.36 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen injectors on April 22, 2025, with completion scheduled for May 13, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The products will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $46.9K delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 6, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,061.54 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injectors on September 2, 2025, with completion expected by September 23, 2025. This competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. The SPE2DX...
- The Defense Logistics Agency awarded a $4,687.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. The contract, which is not set-aside and competitively awarded, has an ultimate completion date of November 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $18,748.72 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injections, with performance in Conshohocken, Pennsylvania and completion targeted for October 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors with an ultimate completion date of September 11, 2025. This competitive award was issued under a firm fixed-price contract structure with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,469.78 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injectors on November 13, 2025. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by December 5, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Tezspire is a biologic medication used in the treatment of asthma and represents one of numerous pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, valued at $2,343.59 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026. The award carries no set-aside designation and was competitively...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WP4Delivery Order
The Defense Logistics Agency awarded a $14,818.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen injectables on November 12, 2025, with completion targeted for December 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and reflects the vendor's role as a critical pharmaceutical distributor for federal medical procurement. Performance will be executed at the company's Corporate Office location in Conshohocken, Pennsylvania. Tezspire is a specialty biologic medication used primarily for severe asthma management, consistent with AmerisourceBergen's extensive portfolio of specialty pharmaceuticals supplied to military and veteran healthcare systems. The delivery order exemplifies the company's ongoing role in fulfilling the DLA's comprehensive pharmaceutical supply requirements across multiple therapeutic domains, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's substantial IDC vehicle enables efficient procurement of diverse medications and medical supplies on a global basis, positioning the company as a key vendor for military healthcare logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 11/12/25 |